164 related articles for article (PubMed ID: 25420468)
1. An evaluation of the preferences of patients with psoriasis between systemic psoralen plus ultraviolet A and bath psoralen plus ultraviolet A.
Alshiyab D; Chin MF; Edwards C; Anstey AV
Br J Dermatol; 2015; 172(5):1457-8. PubMed ID: 25420468
[No Abstract] [Full Text] [Related]
2. Bath psoralen plus ultraviolet A for hidradenitis suppurativa: a review of 13 patients.
Shareef M; Dawe R
Br J Dermatol; 2011 Apr; 164(4):895-6. PubMed ID: 21166664
[No Abstract] [Full Text] [Related]
3. Efficacy of bath psoralen plus ultraviolet A (PUVA) vs. system PUVA in psoriasis: a prospective, open, randomized, multicentre study.
Berneburg M; Herzinger T; Rampf J; Hoetzenecker W; Guenova E; Meisner C; Maetzke J; Schaefer T; Eberlein B; Scharffetter-Kochanek K; Rocken M
Br J Dermatol; 2013 Sep; 169(3):704-8. PubMed ID: 23772997
[TBL] [Abstract][Full Text] [Related]
4. Role of bath psoralen plus ultraviolet A in early-stage mycosis fungoides.
Pavlotsky F; Hodak E; Ben Amitay D; Barzilai A
J Am Acad Dermatol; 2014 Sep; 71(3):536-41. PubMed ID: 24836546
[TBL] [Abstract][Full Text] [Related]
5. Psoralen and ultraviolet a light therapy for psoriasis.
Stern RS
N Engl J Med; 2007 Aug; 357(7):682-90. PubMed ID: 17699818
[No Abstract] [Full Text] [Related]
6. Comparison of clinical and cost-effectiveness of psoralen + ultraviolet A versus psoralen + sunlight in the treatment of chronic plaque psoriasis in a developing economy.
Aggarwal K; Khandpur S; Khanna N; Sharma VK; Pandav CS
Int J Dermatol; 2013 Apr; 52(4):478-85. PubMed ID: 23431966
[TBL] [Abstract][Full Text] [Related]
7. The Science and (Lost) Art of Psoralen Plus UVA Phototherapy.
Richard EG
Dermatol Clin; 2020 Jan; 38(1):11-23. PubMed ID: 31753184
[TBL] [Abstract][Full Text] [Related]
8. Bath-PUVA therapy improves impaired resting regulatory T cells and increases activated regulatory T cells in psoriasis.
Kubo R; Muramatsu S; Sagawa Y; Saito C; Kasuya S; Nishioka A; Nishida E; Yamazaki S; Morita A
J Dermatol Sci; 2017 Apr; 86(1):46-53. PubMed ID: 28139335
[TBL] [Abstract][Full Text] [Related]
9. Bath psoralen+ultraviolet A photochemotherapy vs. narrow band-ultraviolet B in psoriasis: a comparison of clinical outcome and effect on circulating T-helper and T-suppressor/cytotoxic cells.
Salem SA; Barakat MA; Morcos CM
Photodermatol Photoimmunol Photomed; 2010 Oct; 26(5):235-42. PubMed ID: 20831697
[TBL] [Abstract][Full Text] [Related]
10. Treatment of cutaneous sarcoid with topical gel psoralen and ultraviolet A.
Gleeson CM; Morar N; Staveley I; Bunker CB
Br J Dermatol; 2011 Apr; 164(4):892-4. PubMed ID: 21143466
[No Abstract] [Full Text] [Related]
11. A randomized controlled trial of narrowband ultraviolet B vs bath-psoralen plus ultraviolet A photochemotherapy for psoriasis.
Dawe RS; Cameron H; Yule S; Man I; Wainwright NJ; Ibbotson SH; Ferguson J
Br J Dermatol; 2003 Jun; 148(6):1194-204. PubMed ID: 12828749
[TBL] [Abstract][Full Text] [Related]
12. Bath vs. oral psoralen plus ultraviolet A: is one more effective than the other?
Wolf P
Br J Dermatol; 2013 Sep; 169(3):492-3. PubMed ID: 24033156
[No Abstract] [Full Text] [Related]
13. Paired comparison of bathwater versus oral delivery of 8-methoxypsoralen in psoralen plus ultraviolet: A therapy for chronic palmoplantar psoriasis.
Hofer A; Fink-Puches R; Kerl H; Quehenberger F; Wolf P
Photodermatol Photoimmunol Photomed; 2006 Feb; 22(1):1-5. PubMed ID: 16436174
[TBL] [Abstract][Full Text] [Related]
14. Treatment of plaque-type localized scleroderma with retinoic acid and ultraviolet A plus the photosensitizer psoralen: a case series.
Ozdemir M; Engin B; Toy H; Mevlitoglu I
J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):519-21. PubMed ID: 18363929
[No Abstract] [Full Text] [Related]
15. Inflammatory markers of cardiovascular disease risk in Portuguese psoriatic patients: relation with narrow-band ultraviolet B and psoralen plus ultraviolet A.
Coimbra S; Oliveira H; Neuparth MJ; Figueiredo A; Rocha-Pereira P; Santos-Silva A
Int J Dermatol; 2014 Mar; 53(3):393-6. PubMed ID: 24372482
[No Abstract] [Full Text] [Related]
16. Randomized, double-blind, placebo-controlled evaluation of the efficacy of oral psoralen plus ultraviolet A for the treatment of plaque-type psoriasis using the Psoriasis Area Severity Index score (improvement of 75% or greater) at 12 weeks.
Sivanesan SP; Gattu S; Hong J; Chavez-Frazier A; Bandow GD; Malick F; Kricorian G; Koo J
J Am Acad Dermatol; 2009 Nov; 61(5):793-8. PubMed ID: 19766350
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of psoralen plus ultraviolet A therapy vs. biologics in moderate to severe chronic plaque psoriasis: retrospective data analysis of a patient registry.
Inzinger M; Heschl B; Weger W; Hofer A; Legat FJ; Gruber-Wackernagel A; Tilz H; Salmhofer W; Quehenberger F; Wolf P
Br J Dermatol; 2011 Sep; 165(3):640-5. PubMed ID: 21564068
[TBL] [Abstract][Full Text] [Related]
18. Psoralen plus ultraviolet A light phototherapy effectiveness.
Feldman SR
J Am Acad Dermatol; 2010 Oct; 63(4):718. PubMed ID: 20846573
[No Abstract] [Full Text] [Related]
19. Treatment of pustular psoriasis: from the Medical Board of the National Psoriasis Foundation.
Robinson A; Van Voorhees AS; Hsu S; Korman NJ; Lebwohl MG; Bebo BF; Kalb RE
J Am Acad Dermatol; 2012 Aug; 67(2):279-88. PubMed ID: 22609220
[TBL] [Abstract][Full Text] [Related]
20. Comparative evaluation of NBUVB phototherapy and PUVA photochemotherapy in chronic plaque psoriasis.
Dayal S; ; Jain VK
Indian J Dermatol Venereol Leprol; 2010; 76(5):533-7. PubMed ID: 20826993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
